![Russ B. Altman](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Russ B. Altman is the founder of Personalis, Inc. founded in 2011.
He currently serves as an Advisory Board member at Digitaldx Ventures Management LLC.
Previously, he worked as a Director at Youscript, Inc.
| Unternehmen | Position | Beginn |
|---|---|---|
Digitaldx Ventures Management LLC
 Digitaldx Ventures Management LLC Investment ManagersFinance Digitaldx Ventures invests in companies located in the United States. The firm focuses on companies operating in the fields of artificial intelligence and healthcare sectors. It provides financing for early stage capital requirements. | Berater | - |
| Unternehmen | Position | Ende |
|---|---|---|
Youscript, Inc.
 Youscript, Inc. Packaged SoftwareTechnology Services Provides pharmacogenomics research, insights and software solutions that help make precision prescribing possible | Direktor/Vorstandsmitglied | - |
| PERSONALIS, INC. | Gründer | - |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
| Private Unternehmen | 3 |
|---|---|
Personalis, Inc.
 Personalis, Inc. Medical/Nursing ServicesHealth Services Operates as a cancer genomics company which transforms the development of next-generation therapies | Health Services |
Digitaldx Ventures Management LLC
Digitaldx Ventures Management LLC Investment ManagersFinance Digitaldx Ventures invests in companies located in the United States. The firm focuses on companies operating in the fields of artificial intelligence and healthcare sectors. It provides financing for early stage capital requirements. | Finance |
Youscript, Inc.
Youscript, Inc. Packaged SoftwareTechnology Services Provides pharmacogenomics research, insights and software solutions that help make precision prescribing possible | Technology Services |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen
Wählen Sie MarketScreener 
